Merck & Co., the second largest U.S. drugmaker, announced that it will buy commercial rights for an experimental Ebola vaccine developed by NewLink Genetics Corp. Merck will split the total of $50 million in two payments. First, the buyer will offer $30 million upfront. When the next stage of clinical trials will be completed in the first months of 2015, Merck will pay the remaining $20 … [Read more...]
You are here: Home / Archives for Public Health Agency of Canada